ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

120
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Refresh
bullishPosco Future M
10 Jul 2024 05:50

KRX New Deal Index Rebalance Preview: Lots of Change; Shift Up Listing Adds to It

There should be 1 change for each of the Battery, Bio and Game indices plus 2 changes for each of the Internet and BBIG indices. The Shift Up...

Logo
285 Views
Share
03 Jul 2024 06:00

KRX Short Interest Weekly (Jun 28th): Lg Electronics, Hyundai Motor

We analyzed KRX short interest report for the past week and highlighted short interest changes in Lg Electronics, Hyundai Motor.

Logo
254 Views
Share
21 Jun 2024 14:23

Mandatory Block Deal Pre-Announcement Requirement in Korea Starting 24 July: Impact on Block Deals

According to Seoul Economic Daily, LG Chem has been tapping various institutional investors for a potential block deal sale of about 1 trillion won...

Logo
1.1k Views
Share
05 Jun 2024 12:05

KRX Short Interest Weekly (May 31st): Enchem, Sk Hynix, Samsung Electronics, Doosan Enerbility

We analyzed KRX short interest report for the past week and highlighted short interest changes in Enchem, Sk Hynix, Samsung Electronics, Doosan...

Logo
268 Views
Share
28 Feb 2024 06:00

KRX Short Interest Weekly (Feb 23rd): Posco Holdings, Rotem

We analyzed KRX short interest report for the past week and highlighted short interest changes in Posco Holdings, Rotem.

Logo
221 Views
Share
x